acth (4-10) has been researched along with Body Weight in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dodt, C; Hörster, R; Jacobs, F; Lehnert, H; Sayk, F; Wellhöner, P | 1 |
| Biebermann, H; Grüters, A; Krude, H; Mullis, PE; Schnabel, D; Tansek, MZ; Theunissen, P | 1 |
| Born, J; Fehm, HL; Hallschmid, M; McGregor, G; Smolnik, R | 1 |
| Alfeeva, LY; Andreeva, LA; Dolotov, OV; Dubynina, EV; Engele, J; Grivennikov, IA; Inozemtseva, LS; Kamensky, AA; Karpenko, EA; Levitskaya, NG; Myasoedov, NF; Novosadova, EV; Rozyczka, J; Seredenina, TS | 1 |
| Benedict, C; Born, J; Fehm, HL; Hallschmid, M; Kern, W; Perras, B; Schultes, B | 1 |
2 trial(s) available for acth (4-10) and Body Weight
| Article | Year |
|---|---|
Intranasal application of the melanocortin 4 receptor agonist MSH/ACTH(4-10) in humans causes lipolysis in white adipose tissue.
Topics: Abdominal Fat; Adipose Tissue, White; Administration, Intranasal; Adrenocorticotropic Hormone; Adult; Blood Pressure; Body Weight; Cross-Over Studies; Double-Blind Method; Energy Metabolism; Glycerol; Heart Rate; Humans; Lipolysis; Male; Microdialysis; Muscle, Skeletal; Nootropic Agents; Peptide Fragments; Receptor, Melanocortin, Type 4; Sympathetic Nervous System | 2012 |
Overweight humans are resistant to the weight-reducing effects of melanocortin4-10.
Topics: Administration, Intranasal; Adrenocorticotropic Hormone; Adult; Body Composition; Body Weight; Double-Blind Method; Drug Resistance; Humans; Hydrocortisone; Insulin; Leptin; Male; Middle Aged; Overweight; Peptide Fragments | 2006 |
3 other study(ies) available for acth (4-10) and Body Weight
| Article | Year |
|---|---|
Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10.
Topics: Adrenocorticotropic Hormone; Basal Metabolism; Body Weight; Child, Preschool; DNA Mutational Analysis; Genotype; Hair Color; Humans; Infant; Infant, Newborn; Obesity; Peptide Fragments; Phenotype; Pro-Opiomelanocortin; Thyroid Gland; Thyroid Hormones | 2003 |
Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.
Topics: Administration, Intranasal; Adrenocorticotropic Hormone; Animals; Avoidance Learning; Body Weight; Brain-Derived Neurotrophic Factor; Cognition; Conditioning, Psychological; Dose-Response Relationship, Drug; Exons; Hippocampus; Nootropic Agents; Peptide Fragments; Rats; Reaction Time; Receptor, trkB; RNA, Messenger; Up-Regulation | 2006 |
Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders.
Topics: Adipose Tissue; Administration, Intranasal; Adrenocorticotropic Hormone; Body Weight; Central Nervous System; Cognition Disorders; Female; Humans; Hypoglycemic Agents; Insulin; Male; Melanocyte-Stimulating Hormones; Metabolic Diseases; Neuropeptides; Nootropic Agents; Obesity; Peptide Fragments; Receptors, Melanocortin; Satiety Response; Signal Transduction | 2008 |